Lupin Share Price
2110.00-22.00 (-1.03%)
+8.14% past 1 Year
News
Kotak maintains Add on Lupin, highlights margin and growth drivers
Equity
LUPIN
Citi downgrades Lupin to Sell, cuts target on weaker US outlook
Equity
LUPIN
Bernstein retains Outperform on Lupin after favorable US patent ruling
Equity
LUPIN
Lupin signs exclusive Europe deal for Yuvezitm with Visus Therapeutics
Equity
LUPIN
Lupin secures final US FDA approval for Pitolisant tablets ANDA
Equity
LUPIN
Lupin reports Rs 17.24 crores NSE block trade in 75,946 shares
Equity
LUPIN
Lupin wins US approval for sodium zirconium cyclosilicate oral suspension
Equity
LUPIN
Lupin gets US FDA approval for sodium zirconium cyclosilicate oral suspension
Equity
LUPIN
Lupin sees US business returning to growth from FY28 on pipeline strength
Equity
LUPIN
Lupin affirms high single digit revenue growth and 25 percent EBITDA margin
Equity
LUPIN
Lupin Q1 EBITDA beats estimates with stronger year-on-year margin expansion
Equity
LUPIN
Lupin Q1 revenue surges YoY, comfortably beating street revenue estimates
Equity
LUPIN
Lupin Q1 FY27 consolidated net profit beats estimates on strong YoY growth
Equity
LUPIN
Lupin sees Rs 29.03 crores NSE block trade in 121,534 shares
Equity
LUPIN
Lupin gains US FDA approval for diazepam injection USP product
Equity
LUPIN
Lupin receives US FDA approval for Sugammadex injection, boosting complex injectables portfolio
Equity
LUPIN
Lupin receives US FDA approval and launches Sugammadex injection
Equity
LUPIN
Lupin receives US approval for generic Diazepam injectable formulation
Equity
LUPIN
Lupin to hold Q1 earnings call on August 7 at 4 30 PM
Equity
LUPIN
Lupin to review Q1 results on August 6, 2025
Equity
LUPIN